Ferring Pharmaceuticals
Privately held: no public share price
Assets
(3 total)
3Total Assets
2Approved
0Phase 3 / Filed
1Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
| Approved | Glucocorticoid receptorSmall molecule | Inflammatory Bowel Disease Ulcerative Colitis | |
| Approved | AminosalicylateSmall molecule | Inflammatory Bowel Disease Ulcerative Colitis | |
| Phase 2 | IL-6 transProtein / enzyme therapeutic | Inflammatory Bowel Disease Ulcerative Colitis |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.